Granules India Limited (NSE:GRANULES)
India · Delayed Price · Currency is INR 566.15
-13.55 (-2.34%)
Feb 6, 2026, 3:30 PM IST
Granules India Market Cap
Granules India has a market cap or net worth of 136.94 billion as of February 6, 2026. Its market cap has decreased by -5.53% in one year.
Market Cap
136.94B
Enterprise Value
148.82B
Revenue
50.92B
Ranking
n/a
PE Ratio
25.10
Stock Price
566.15
Market Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 136.94B, an increase of 83,551.73%. That is a compound annual growth rate of 33.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 136.94B | -5.72% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 290.97B |
| Wockhardt | 228.87B |
| Piramal Pharma | 215.32B |
| Eris Lifesciences | 199.64B |
| Alembic Pharmaceuticals | 155.61B |
| NATCO Pharma | 152.91B |
| Cohance Lifesciences | 140.31B |
| Alivus Life Sciences | 116.28B |